Anyone researching N-Acetyl Selank will find it described in various places, but the actual regulatory and clinical record is thin. Here is what the available data actually supports.
Key takeaways
- N-Acetyl Selank is an unapproved research compound with no FDA-reviewed label.
- No clinical trials for this compound are currently registered.
- Its molecular formula is C35H59N11O10, with a molecular weight near 793.9 g/mol.
- No adverse event reports are currently on file for this compound.
What N-Acetyl Selank is
N-Acetyl Selank is a synthetic peptide identified by PubChem CID 133082488. It has a molecular formula of C35H59N11O10 and a molecular weight of approximately 793.9 g/mol. There is no FDA-approved label for this compound, meaning no agency-reviewed information exists on its mechanism, indications, or safety profile.
Regulatory and trial status
N-Acetyl Selank is classified as an unapproved research compound. It has not been reviewed or authorized by the FDA for any use, and no dailymed label is on file. As of the most recent data check, no clinical trials involving this compound are registered, so there is no trial-based evidence of safety or effect in humans to summarize.